Tag: Sonnet BioTherapeutics
Sonnet BioTherapeutics ($SONN) stock soars 270% pre-market on $888M deal with Rorschach I LLC
Sonnet BioTherapeutics (NASDAQ: SONN) shares surged an impressive 270.41% in pre-market trading on Monday, July 14, 2025, hitting $19.15 following its business combination agreement...
Sonnet BioTherapeutics, Inc. ($SONN) Seals Definitive Agreement for Business Combination
Sonnet BioTherapeutics, Inc. (SONN) has entered into a definitive agreement for a business combination with Rorschach I LLC, formed by an entity affiliated with...